» Articles » PMID: 23664768

Comparisons of Sarcopenia Defined by IWGS and EWGSOP Criteria Among Older People: Results from the I-Lan Longitudinal Aging Study

Overview
Publisher Elsevier
Specialty General Medicine
Date 2013 May 14
PMID 23664768
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare clinical characteristics of sarcopenia defined by the International Working Group on Sarcopenia (IWGS) and European Working Group on Sarcopenia in Older People (EWGSOP) criteria among older people in Taiwan.

Design: A prospective population-based community study.

Setting: I-Lan County of Taiwan.

Participants: A total of 100 young healthy volunteers and 408 elderly people.

Intervention: None.

Measurements: Anthropometry, skeletal muscle mass measured by dual x-ray absorptiometry, relative appendicular skeletal muscle index (RASM), percentage skeletal muscle index (SMI), 6-meter walking speed, and handgrip strength.

Results: The prevalence of sarcopenia was 5.8% to 14.9% in men and 4.1% to 16.6% in women according to IWGS and EWGSOP criteria by using RASM or SMI as the muscle mass indices. The agreement of sarcopenia diagnosed by IWGS and EWGSOP criteria was only fair by using either RASM or SMI (kappa = 0.448 by RASM, kappa = 0.471 by SMI). The prevalence of sarcopenia was lower by the IWGS definition than the EWGSOP definition, but it was remarkably lower by using RASM than SMI in both criteria. Overall, sarcopenic individuals defined by SMI were older, had a higher BMI but similar total skeletal muscle mass, and had poorer muscle strength and physical performance than nonsarcopenic individuals. However, by using RASM, sarcopenic individuals had less total skeletal muscle mass but similar BMI than nonsarcopenic individuals. Multivariable logistic regression showed that age was the strongest associative factor for sarcopenia in both IWGS and EWGSOP criteria. Obesity played a neutral role in sarcopenia when it is defined by using RASM, but significantly increased the risk of sarcopenia in both criteria by using SMI.

Conclusion: The agreement of sarcopenia defined by IWGS and EWGSOP was only fair, and the prevalence varied largely by using different skeletal muscle mass indices. Proper selections for cutoff values of handgrip strength, walking speed, and skeletal muscle indices with full considerations of gender and ethnic differences were of critical importance to reach the universal diagnostic criteria for sarcopenia internationally.

Citing Articles

Impact of Glucose Profile, Fasting Insulin, and Renal Function on Sarcopenia in Elderly at Single Centered Nursing Home: A Cross-Sectional Structural Equation Model Analysis.

Santoso A, Destra E, Firmansyah Y, Lontoh S J Multidiscip Healthc. 2025; 18:1393-1404.

PMID: 40066249 PMC: 11892493. DOI: 10.2147/JMDH.S486370.


Sarcopenia diagnosis using skeleton-based gait sequence and foot-pressure image datasets.

Naseem M, Kim N, Seo H, Lee J, Chung C, Shin S Front Public Health. 2024; 12:1443188.

PMID: 39664552 PMC: 11631742. DOI: 10.3389/fpubh.2024.1443188.


Mapping computational cognitive profiles of aging to dissociable brain and sociodemographic factors.

Marzuki A, Wong K, Chan J, Na S, Thanaraju A, Phon-Amnuaisuk P NPJ Aging. 2024; 10(1):50.

PMID: 39482289 PMC: 11527976. DOI: 10.1038/s41514-024-00171-3.


Prevalence and severity of sarcopenia in patients on maintenance hemodialysis: a cross-sectional study.

Yang Y, Zeng Y, Lv W, Fu P, Yuan H BMC Nephrol. 2024; 25(1):385.

PMID: 39472785 PMC: 11520690. DOI: 10.1186/s12882-024-03836-z.


Harnessing immunomodulation to combat sarcopenia: current insights and possible approaches.

Zhang N, Zhai L, Wong R, Cui C, Law S, Chow S Immun Ageing. 2024; 21(1):55.

PMID: 39103919 PMC: 11299351. DOI: 10.1186/s12979-024-00458-9.